tuberous sclerosis

Novartis drug Afinitor® approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis
PharmPro
Sat, 10/30/10 - 01:00 pm
Novartis
Afinitor
tuberous sclerosis
brain tumors